ADMA Biologics Inc vs Orion Office REIT Inc — how do they compare? ADMA Biologics Inc trades at $9.81 (market cap $2.22B), while Orion Office REIT Inc trades at $2.72 (market cap $158.01M). The key difference: ADMA Biologics Inc is far larger — about 14× Orion Office REIT Inc's market cap, and Orion Office REIT Inc pays a 2.89% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | ONL | |
|---|---|---|
Market Cap | $2.22B | $158.01M |
Sector | Health | Real Estate |
52-Week High | $20.38 | $3.04 |
52-Week Low | $7.60 | $1.93 |
Enterprise Value | $2.29B | $574.95M |
Dividend Yield | — | 2.89% |
Trailing returns across standard periods
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →Orion Office REIT Inc is a internally-managed REIT engaged in the ownership, acquisition, and management of a diversified portfolio of mission-critical and headquarters office buildings located in high quality suburban markets across the U.S. and leased primarily on a single-tenant net lease basis to creditworthy clients.
Read more on ONL →